Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-6

Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note

Guoqiao Wang, Gary R Cutter, Stacey S Cofield [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons

Nicholas Riley, Christopher Drudge, Morag Nelson [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2014-10

Composite end points to assess delay of disability progression by MS treatments

J Zhang, E Waubant, G Cutter [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 1991-10

Family-Focused Intervention Model

Patricia Caro, Jeffrey L. Derevensky

Topics in Early Childhood Special Education

Open access

Review article

First published 2012

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is there an odd one Out?

Alexis Clapin

Journal of Central Nervous System Disease

Retricted access

Review article

First published 2010-7

Modifiable factors influencing relapses and disability in multiple sclerosis

MB D'hooghe, G. Nagels, V. Bissay [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023

Multilayer perceptron-based self-care early prediction of children with disabilities

Rahman Ali, Jamil Hussain, Seung Won Lee

DIGITAL HEALTH

Open access

Research article

First published 2026-2

Dissecting definitions of disability accrual in relapsing multiple sclerosis—Have we reached standardization yet?

Gabriel Bsteh, Stefanie Marti, Helly Hammer [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2026-4

Assessment of the impact of outcome definitions on power in multiple sclerosis clinical trials

Cynthia X Li, Bonnie I Glanz, Moogeh Baharnoori [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2017-9

The role of natalizumab in the treatment of multiple sclerosis: benefits and risks

Barry A. Singer

Therapeutic Advances in Neurological Disorders

Search results